SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (4434)6/4/1998 6:04:00 PM
From: David S.  Read Replies (1) of 6136
 
I have not looked at AGPH in almost a year. This time, I would like to evaluate it as a possible long candidate, since more than likely, some "fluff" has been removed from the market capitalization. Is there a basic evaluation of the current situation, or can somebody provide one. PS - I do not have a 666 tatoo on my forehead. Last year, I was quite open regarding my opinion that the stock was overvalued, but as prices and product pipelines change, so do issues of over vs. undervaluation. It's as simple as that.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News